Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Farnum Rhonda Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 1,807 shares @ $9.47, valued at $17.1k
08/22/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 10,460 shares @ $9.7, valued at $101.5k
06/12/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 1,790 shares @ $11.13, valued at $19.9k
05/23/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 5,567 shares @ $11.21, valued at $62.4k
03/13/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 4,000 shares @ $10.2, valued at $40.8k
03/03/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 75,000 shares @ $0
02/22/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 7,119 shares @ $10.44, valued at $74.3k
11/22/2022 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 23,268 shares @ $10.85, valued at $252.5k
08/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy